Browse EX-10 agreements

ISABELLA BANK CORPORATION

SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN

PARTICIPATION AGREEMENT

FOR

Gerald Ritzert

March 25, 2026

This Participation Agreement is entered into effective as of March 25, 2026, by Gerald Ritzert(the “Participant”) and Isabella Bank Corporation (together with any successors and affiliates, the “Company”) pursuant to the Isabella Bank Corporation Supplemental Executive Retirement Plan (“Plan”), as amended from time to time.

1. Agreement.The Participant and the Company agree to be bound by the terms of the Plan and the terms of this Participation Agreement with respect to the Participant’s participation in and benefits under the Plan. The terms of the Plan are incorporated into this Participation Agreement by reference. Capitalized terms not otherwise defined in this Participation Agreement have the meaning given in the Plan. In the event of a conflict between the terms of the Plan and the terms of this Participation Agreement, the terms of the Plan shall control except as specifically provided otherwise in the Plan or this Participation Agreement.

2. Effective Date of Participation.The Participant’s participation in the Plan and this Participation Agreement commence effective as of March 25, 2026.

3. Early Retirement Age.The Participant’s Early Retirement Age is age 55.

4. Normal Retirement Age.The Participant’s Normal Retirement Age is age 65.

…

---

Exhibit 10.2

May 6, 2026

PERSONAL AND CONFIDENTIAL

Jeannine Lynch

Re:          Separation Agreement

Dear Jeannine:

This letter will service as a written “notice of termination” pursuant to Section 9.4(iv) of the Employment Agreement between the Lifeward, Inc. f/k/a ReWalk Robotics, Inc. (the “Company”) and you (the “Employment Agreement”).  Your employment with the Company will terminate, effective as of May 3, 2026 (such date, the “Separation Date”).

The Company is also proposing an agreement with you, with the purpose of establishing an amicable arrangement for ending your employment relationship (the “Agreement”).  Regardless of whether you sign the Agreement, each of the below will apply.

\	•	The Company will pay you any accrued wages owed to you through the Separation Date and will pay you any accrued but unused vacation time, which totals $12,055 (the “Final Wage Payment”).  The Final Wage Payment will be paid on the Separation Date.

…

CERTAIN INFORMATION IN THE SCHEDULE I ATTACHED TO THIS AGREEMENT HAS BEEN EXCLUDED FOM THE EXHIBIT AS SUCH INFORMATION IS NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED ([***]).

Agreement

This agreement (the “Agreement”) is entered on the 07th of August 2026 (the “Effective Date”) between Techlott Inc., a company incorporated under the laws of Nevada, registration number 03834R2025 of 447 Broadway 2nd FL, 10013 New York, United States (“Techlott”) and Sunlotto Limited, a company incorporated under the laws of Gambia, registration number 25002617 of Banjul, Gambia (“SL”)

INTRODUCTION

WHEREAS Techlott is the owner of the Platform;

WHEREAS SL holds the Regulatory License;

WHEREAS SL operates and manages the lottery and gaming operation in the Territory, under the Regulatory License;

WHEREAS SL wishes to that Techlott will provide SL with the Offering; and

WHEREAS Accordingly, SL and Techlott wish to enter into a contractual engagement according to which Techlott provides the Offering to SL under the Regulatory License in accordance with the terms and conditions of this Agreement.

THEREFORE, IT IS AGREED THAT:

1 DEFINITIONS AND INTERPRETATION

…

***Certain identified information has been excluded from the exhibit because it both (i) is not material and (ii) is the type that the company treats as private or confidential. Such omitted information is indicated by brackets (“[***]”) in this exhibit.***

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT(this “Agreement”) is dated as of August 14, 2026, by and among Skye Bioscience, Inc., a Nevada corporation (the “Company”), and each of the entities listed on Exhibit Aattached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, concurrently with the execution and delivery of this Agreement, the Company is entering into a Transaction Agreement (the “Transaction Agreement”) with Redx Pharma Limited, a private limited company incorporated in England and Wales with registered number 07368089 (“Redx”), pursuant to which the Company intends to acquire the entire issued and to be issued share capital of Redx, which acquisition is intended to be effected by means of a scheme of arrangement of Redx under Part 26 of the UK Companies Act 2006 (the “Scheme of Arrangement”), in accordance with and subject to the terms set forth in the Transaction Agreement (the “Transaction”);

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act;

…

August 13, 2026

PERSONAL AND CONFIDENTIAL

** **

Mr. Mark Emalfarb, Chief Executive Officer

Dyadic International, Inc.

1044 North U.S. Highway One

Suite 201

Jupiter, FL 33477-5094

Re:	DYAI | Registered Direct and PIPE Offering | Placement Agent Agreement

** **

Dear Mr. Emalfarb:

The purpose of this placement agent agreement is to outline our agreement pursuant to which Aegis Capital Corp. (“Aegis” or the “Placement Agent”) will act as the placement agent on a “best efforts” basis in connection with the proposed Registered Direct and PIPE Offering (the “Placement”) by Dyadic International, Inc. (collectively, with its subsidiaries and affiliates, the “Company”) of units consisting of its shares of Common Stock and warrants to purchase its shares of Common Stock (the “Securities”). This placement agent agreement sets forth certain conditions and assumptions upon which the Placement is premised. The Company expressly acknowledges and agrees that Aegis’s obligations hereunder are on a reasonable “best efforts” basis only and that the execution of this Agreement does not constitute a commitment by Aegis to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of Aegis with respect to securing any other financing on behalf of the Company. The Company confirms that

…

** **

REGISTRATION RIGHTS AGREEMENT

** **

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 13, 2026, between Dyadic International, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

This Agreement is made pursuant to the Securities Purchase Agreement with respect to the sale of Warrants under Regulation D, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

The Company and each Purchaser hereby agrees as follows:

1.	Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

1.1. “Advice” shall have the meaning set forth in Section 6.3.

…

E****xhibit 10.2

** **

SECURITIES PURCHASE AGREEMENT

** **

This Securities Purchase Agreement (this “Agreement”) is dated as of August 13, 2026, between Dyadic International, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, certain securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

…